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Abstract
SUMO modification of transcription factors is linked to repression of transcription. The physiological significance of SUMO
attachment to a particular transcriptional regulator, however, is largely unknown. We have employed the ubiquitously
expressed murine transcription factor Sp3 to analyze the role of SUMOylation in vivo. We generated mice and mouse
embryonic fibroblasts (MEFs) carrying a subtle point mutation in the SUMO attachment sequence of Sp3 (IKEE553D
mutation). The E553D mutation impedes SUMOylation of Sp3 at K551 in vivo, without affecting Sp3 protein levels. Expression
profiling revealed that spermatocyte-specific genes, such as Dmc1 and Dnahc8, and neuronal genes, including Paqr6, Rims3,
and Robo3, are de-repressed in non-testicular and extra-neuronal mouse tissues and in mouse embryonic fibroblasts
expressing the SUMOylation-deficient Sp3E553D mutant protein. Chromatin immunoprecipitation experiments show that
transcriptional de-repression of these genes is accompanied by the loss of repressive heterochromatic marks such as H3K9
and H4K20 tri-methylation and impaired recruitment of repressive chromatin-modifying enzymes. Finally, analysis of the
DNA methylation state of the Dmc1, Paqr6, and Rims3 promoters by bisulfite sequencing revealed that these genes are
highly methylated in Sp3wt MEFs but are unmethylated in Sp3E553D MEFs linking SUMOylation of Sp3 to tissue-specific CpG
methylation. Our results establish SUMO conjugation to Sp3 as a molecular beacon for the assembly of repression
machineries to maintain tissue-specific transcriptional gene silencing.
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Introduction
A plethora of proteins involved in regulating gene expression
such as promoter-specific transcription factors, cofactors and
chromatin-modifying enzymes are reversibly modified by the
Small Ubiquitin-like MOdifier SUMO (reviewed in [1,2]). With
few exceptions, SUMO modification of transcriptional regulators
correlates with repression of transcription [3–5].
The ubiquitously expressed transcription factor Sp3 represents a
well-studied paradigm for regulation of activity by SUMOylation
[6–8]. Sp3 belongs to the Sp (specificity protein) family of
transcription factors that is implicated in the expression of a wide
variety of genes including housekeeping, tissue-specific, develop-
mentally and cell-cycle regulated genes [9–12]. A major feature of
Sp3 is that, depending on promoter context, it can either activate
or repress transcription in reporter gene assays [6,7,13]. Two
glutamine-rich domains are known to exercise the activation
function of Sp3 [13]; whereas the repressive activity of Sp3 is
mediated by attachment of SUMO to lysine 551. K551 lies within
the SUMO consensus motif IKEE located between the second Q-
rich activation domain and the DNA-binding domain [6,7]
(Figure 1A and 1B). The functional complexity of Sp3 is further
increased in vivo by the expression of four different isoforms that
differ in their N-terminal extension [14]. All of these isoforms are
SUMO-modified at K551, giving rise to a composite pattern of at
least eight distinct protein species [14].
Previous investigations of the molecular events associated with
Sp3-SUMO-dependent repression have provided mechanistic
clues underlying SUMO-dependent gene silencing [15,16].
SUMO-modification can act as a signal for the recruitment of
various chromatin-associated repression components including the
chromatin remodeler Mi-2, the MBT-domain proteins L3MBTL1
and L3MBTL2, heterochromatin protein 1 (HP1) and the histone
methyltransferases (HMTs) SETDB1/ESET and SUV4-20H,
concomitant with the establishment of repressive histone modifi-
cations such as H3K9 and H4K20 tri-methylation [16].
Despite extensive studies on the repression function of
SUMOylated Sp3 and other transcription factors, the significance
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of SUMO attachment for the expression of endogenous genes in
vivo is still largely unknown. Here, we report the generation of mice
and mouse embryonic fibroblasts (MEFs) with a point mutation in
the SUMO attachment sequence of Sp3. Expression profiling
revealed that SUMOylation of Sp3 is required for silencing of
spermatocyte-specific genes such as Dmc1 and Dnahc8 in somatic
cells, and neuronal genes including Paqr6, Rims3 and Robo3 in non-
neuronal cells. Transcriptional de-repression of these genes in
MEFs expressing the Sp3E553D mutant protein is accompanied by
the loss of repressive heterochromatic marks such as H3K9 and
H4K20 tri-methylation, impaired recruitment of repressive
chromatin-modifying enzymes and loss of DNA methylation.
Our results establish that SUMO-modification of Sp3 acts as a
platform for the assembly of repression machineries to maintain
tissue-specific transcriptional gene silencing.
Results
Generating mutant mice deficient for SUMO modification
of Sp3
To investigate the in vivo function of Sp3 SUMOylation, we
generated mice in which the SUMO attachment site IK551EE is
mutated to IK551ED (Figure 1A). We chose glutamic acid residue
E553 for mutation because K551 might also be a target for other
posttranslational modifications such as methylation or acetylation.
A vector carrying the Sp3E553D mutation and a floxed neomycin-
resistance cassette was used for targeting of ES cells to generate
heterozygous mutant mice (Figure 1B; Figure S1). The neomycin-
resistance gene was subsequently removed by mating with
appropriate Cre recombinase-expressing mice [17]. Mice carrying
the Sp3E553D mutation will from hereon be referred to as Sp3
knockin (Sp3ki) mutant. Heterozygous Sp3wt/ki mice and homo-
zygous Sp3ki/ki mice were fertile, born at the expected Mendelian
frequency and exhibited no obvious phenotype (Table S1).
To ensure that the E553D mutation impaired SUMOylation of
Sp3, we performed Western blotting of adult mouse tissues and
MEFs derived from E13.5 embryos. SUMO-modification of Sp3
was readily detectable in Sp3wt and heterozygous Sp3wt/ki but not
in homozygous Sp3ki/ki tissues and MEFs (Figure 1C; Figure S1).
This result demonstrates that the glutamic acid residue within the
SUMOylation consensus motif YKXE is absolutely essential for
the attachment of SUMO to endogenous Sp3. We conclude that
the E553D mutation carried by Sp3ki/ki mice impedes SUMOyla-
tion of Sp3 at K551 in vivo, without affecting Sp3 protein levels.
SUMOylated Sp3 represses spermatocyte-specific and
neuronal genes
To identify genes that are regulated by SUMO-modified Sp3,
we performed gene expression profiling with RNA extracted from
primary Sp3wt and Sp3ki/ki MEFs derived from E13.5 littermates.
This identified 68 genes that were upregulated and 7 genes that
were downregulated by more than 2-fold in Sp3ki/ki MEFs (Table
S2). Notably, top candidate genes that were upregulated in Sp3ki/
ki MEFs encode developmentally-regulated meiotic and neuronal
proteins. Dmc1 and Dnahc8 are expressed in meiotic spermatocytes
and encode a RecA-like recombinase and a flagellar protein,
respectively [18,19]. Paqr6, Rims3 and Robo3 are expressed in the
central nervous system [20–22]. The expression pattern of another
upregulated gene (Villin-like, Vill) is largely unknown, although a
low level of expression in early embryogenesis was reported [23].
To validate aberrant de-repression of these genes, we analyzed
their expression in MEF cultures by quantitative RT-PCR. Dmc1,
Dnahc8, Paqr6, Rims3, Robo3 and Vill mRNA levels were elevated in
primary Sp3ki/ki MEFs as well as in immortalized Sp3ki/ki MEFs
(Figure 2). We also analyzed expression of Dmc1, Dnahc8, Paqr6,
Rims3, Robo3 and Vill in Sp3-deficient (Sp3-/-) MEFs obtained
from E13.5 Sp3 knockout embryos [24]. Consistent with an Sp3-
SUMO-dependent silencing function, all six genes were upregu-
lated also in Sp3-/- MEFs as compared to corresponding Sp3wt
Figure 1. Targeting of the mouse Sp3 SUMO attachment site.
(A) Sp3 is posttranslationally modified at K551 within the SUMO
consensus sequence YKXE. In Sp3ki/ki mice the IK551EE553 sequence is
replaced by IK551ED553. (B) Schematic presentation of Sp3 protein
structure and part of the Sp3 gene. The glutamine-rich activation
domains A and B, the SUMO attachment site (IKEE) within the inhibitory
domain (ID) and the zinc fingers (black bars) of the DNA-binding
domain are indicated. Arrows depict the four translational start sites
and the lengths of the resulting Sp3 isoforms are shown. In the mutated
Sp3ki allele, wild type exon 5 is replaced by the mutant exon 5 carrying
the E553D mutation. (C) Sp3ki/ki mice lack SUMO modification of Sp3.
MEFs obtained from Sp3wt (wt) and Sp3ki/ki (ki) embryos at E13.5 were
subjected to Western blot analysis with Sp3 antibodies. The asterisk
denotes an aspecific band.
doi:10.1371/journal.pgen.1001203.g001
Author Summary
Cell type–specific gene expression patterns are largely
regulated by positively or negatively acting transcription
factors binding to promoter and enhancer elements. The
ubiquitous transcription factor Sp3 represents a paradigm
for a dual function transcription factor as it can activate
and repress transcription. The repression function of Sp3 is
mediated by attachment of a small protein designated
SUMO to a single lysine residue. SUMOylation of Sp3 thus
acts as a molecular switch that determines whether Sp3
acts as an activator or repressor. In this study, we have
generated mice with a subtle mutation in the SUMO
attachment site of Sp3. We found that several spermato-
cyte- and brain-specific genes that are silenced in non-
testicular and extra-neuronal tissues of wild-type animals
become aberrantly de-repressed in mice in which the
SUMO attachment site of Sp3 is mutated. De-repression of
these genes is accompanied with dramatic epigenetic
changes including the loss of repressive histone methyl-
ation marks and, most significantly, loss of DNA methyl-
ation. Our findings suggest that SUMO modification of a
transcription factor can act as a molecular beacon for the
assembly of repression machineries to maintain tissue-
specific transcriptional gene silencing in vivo.
Epigenetic Silencing by SUMOylated Sp3
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MEFs derived from littermates (Figure 2). We also performed
immunoblot analysis for Dmc1 and Dnahc8 but failed to detect
these proteins probably due to their low expression levels.
However, de-repression of the Dmc1 gene in Sp3ki/ki and Sp3-/-
MEFs was verified with different amplimers spanning different
exons (data not shown), thereby precluding the possibility that the
qRT-PCR analyses detected an aberrant Dmc1 transcript.
De-repression of Dmc1, Dnahc8, Paqr6, Rims3, Robo3 and Vill in
Sp3ki/ki and Sp3-/- MEF cultures suggested that SUMO
modification of Sp3 might be essential for silencing these genes
in tissues other than testis and brain, respectively. We analyzed
RNA from various tissues of adult Sp3wt and Sp3ki/ki mice. As
expected, Dmc1 and Dnahc8 were strongly expressed in testis of
Sp3wt and Sp3ki/ki mice at similar levels but were not or only
marginally expressed in other tissues such as brain, heart, intestine,
kidney, liver, lung and spleen. In Sp3ki/ki mice, Dmc1 and Dnahc8
mRNA levels were significantly higher in all tissues (Figure 3).
However, the amount of RNA in testis was still one to three orders
of magnitude higher indicating that testis-specific activators further
enhance expression of Dmc1 and Dnahc8 in spermatocytes.
Previous reports have attributed silencing of several meiotic and
male germ-line-specific genes in somatic cells such as Smc1ß and
Stag3 to E2F6 [25,26], a repressive member of the E2F family of
transcription factors. We analyzed expression of Smc1ß and Stag3
in tissues of Sp3ki/ki mice as well. Both genes were only detectable
in testis RNA preparations and were not de-repressed in non-
testicular Sp3ki/ki tissues or Sp3ki/ki MEFs (data not shown). Vice
versa, the Dmc1 gene is not de-repressed in E2F6-/- MEFs [27]
although the Dmc1 promoter region is bound by E2F6 in vivo at a
conserved binding site [27]. This observation suggests that
different transcription factors and mechanisms are responsible
for repressing spermatocyte-specific genes in somatic cells.
Consistent with published data, Paqr6, Rims3 and Robo3 mRNA
levels were highest in mouse brain. Strikingly, all three genes were
also highly expressed in testis and in the case of Robo3 also in
kidney. In all other organs these mRNAs were either not
detectable or expressed only at a very low level (Figure 3).
Nevertheless, expression of Paqr6, Rims3 and Robo3 as well as Vill
mRNA was significantly elevated in several organs of Sp3ki/ki mice
(Figure 3). Taken together, these results demonstrate that
SUMOylation of Sp3 is essential for silencing of a subset of
spermatocyte-specific and neuronal genes in somatic and non-
neuronal tissues, respectively, implying an important role of the
SUMO moiety attached to Sp3 in establishing tissue-specific gene
expression patterns.
Gene silencing of meiotic and neuronal genes is rescued
by re-expression of SUMOylation-competent Sp3 in
Sp3-/- MEFs
To substantiate the notion that SUMOylation of Sp3 is directly
responsible for silencing testis- and neuronal-specific genes in
MEFs, we re-expressed the short and long isoforms of Sp3 (Sp3si-
wt and Sp3li-wt) in Sp3-/- MEFs by retroviral transduction
(Figure 4A). As controls, we used the corresponding SUMOyla-
tion-deficient Sp3 mutants (Sp3si-K551D and Sp3li-K551R).
Particularly, re-expression of the long isoform of Sp3 resulted in
significantly reduced expression of the Dmc1, Dnahc8, Paqr6, Rims3,
Robo3 and Vill genes. Repression of these genes by re-expression of
the small isoforms of Sp3 was less pronounced (Figure 4B–4G).
The weaker effects observed with the small isoforms of Sp3 could
be due to their lower expression level (see Figure 4A). Potentially,
simultaneous expression of all four wild type Sp3 isoforms would
be necessary to restore repression completely. Nevertheless, in
contrast to the wild type Sp3 isoforms, introduction of the
SUMOylation-deficient Sp3 mutants failed to rescue gene
silencing but instead further enhanced expression of these genes
(Figure 4B–4G). These results show that reintroduction of Sp3
partially reverses de-repression of these genes in a SUMOylation-
dependent manner.
Sp3 is bound to the promoters of repressed genes in vivo
To analyze whether Sp3 is bound to the promoters of genes that
are repressed by Sp3-SUMO, we performed ChIP analyses.
Because of the lack of precise promoter information for Dnahc8,
Robo3 and Vill we focused on Dmc1, Paqr6 and Rims3. All three
promoters contain several potential binding sites for Sp3.
Figure 2. SUMOylation of Sp3 is required for silencing of spermatocyte-specific and neuronal genes in MEFs. Quantitative real-time
RT-PCR analysis of Dmc1, Dnahc8, Paqr6, Rims3, Robo3 and Vill expression in primary (p) and immortalized (i) Sp3wt (wt), Sp3ki/ki (ki) and Sp3-/- (2/2)
MEFs. Normalized mRNA levels are presented relative to wild type MEFs arbitrarily set to 1. Data are expressed as mean +/2SD.
doi:10.1371/journal.pgen.1001203.g002
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Figure 4. Sp3-SUMO–dependent rescue of gene silencing. Sp3-/- MEFs were transduced with retroviral expression vectors for the
SUMOylation-competent long and short Sp3 isoforms (Sp3li-wt and Sp3si-wt), and corresponding SUMOylation-deficient mutants (Sp3li-K551R and
Sp3si-K551D), respectively. (A) Immunoblot analysis of the various MEF cultures. (B–G) Expression of Dmc1, Dnahc8, Paqr6, Robo3, Rims3 and Vill in
rescue MEFs. Gapdh-normalized mRNA expression levels are presented relative to the expression in wild type MEFs arbitrarily set to 1. Data are
expressed as mean +/2SD.
doi:10.1371/journal.pgen.1001203.g004
Figure 3. SUMOylation of Sp3 restricts tissue-specific gene expression in mouse organs. RNA from adult mouse organs was analyzed for
Dmc1, Dnahc8, Villin-like, Paqr6, Rims3 and Robo3 expression by qRT-PCR. Expression levels were normalized to Gapdh mRNA and are presented
relative to testis (Dmc1, Dnahc8 and Villin-like) or brain (Paqr6, Rims3 and Robo3) RNA arbitrarily set to 100. Abbreviations: Br, brain; Te, testis; He,
heart; In, intestine; Ki, kidney; Li, liver, Lu, lung; Sp, spleen. Data are expressed as mean +/2SD.
doi:10.1371/journal.pgen.1001203.g003
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Antibodies to Sp3 precipitated all three promoters from Sp3wt and
Sp3ki/ki MEF chromatin but not from Sp3-/- MEF chromatin
(Figure 5), demonstrating that both wild type Sp3 and the
SUMOylation-deficient Sp3E553D mutant were bound to the
Dmc1, Paqr6 and Rims3 promoters.
Repressive chromatin components are enriched on
promoters silenced by Sp3-SUMO
Next, we analyzed the Dmc1, Paqr6 and Rims3 promoters for the
presence of repressive histone modifications (Figure 5). In Sp3wt
MEFs, the H3K27me3 mark is abundantly present at the Dmc1
and Rims3 promoters but not at the Paqr6 promoter. Moreover,
this mark is not or only marginally reduced in the absence of
SUMOylated Sp3 suggesting that H3K27me3 does not contribute
to SUMO-dependent gene silencing of these three genes. In
contrast, H3K9me3 and H4K20me3 marks are present at all three
promoters in Sp3wt MEFs but are strongly reduced in Sp3ki/ki and
in Sp3-/- MEFs. Consistently, HP1a, which binds H3K9me3, is
present at the Dmc1, Paqr6 and Rims3 promoters in Sp3wt MEFs
but not in Sp3ki/ki and Sp3-/- MEFs. Thus, the presence or
absence of H3K9me3, H4K20me3 and HP1a at the Dmc1, Paqr6
and Rims3 promoters correlates strictly with the repressed or de-
repressed state of these genes. We also analyzed for the presence of
H3K4 trimethylation, an epigenetic mark characteristic for
promoter-proximal nucleosomes of most active as well as inactive
genes [28]. The co-occurrence of H3K9me3, H3K27me3 and
H3K4me3 marks is a characteristic property of ‘‘bivalent’’
promoters of euchromatic genes in ES cells, believed to reflect a
repressed but poised transcriptional state [29]. The H3K4me3
mark was abundantly present on the Dmc1, Paqr6 and Rims3
promoters in Sp3wt MEFs. In Sp3ki/ki MEFs we found an
approximately 2-fold and 3-fold increase of H3K4 trimethylation
on the Dmc1 promoter and on the Paqr6 promoter, respectively,
but not on the Rims3 promoter (Figure 5). In Sp3-/- cells, higher
H3K4me3 levels were detected on the Dmc1 promoter but not on
the Rims3 and Paqr6 promoters. Thus, there is no strict correlation
between the changes of the H3K4me3 mark and the expression
state of the different target genes.
Our previous investigations revealed that the establishment of
repressive nucleosomal signatures on a chromatinized Gal4-driven
reporter gene by Gal4-Sp3-SUMO involves the recruitment of the
histone methyltransferase SETDB1, the chromatin remodeler Mi-2,
and the chromatin-compacting MBT-domain proteins L3MBTL1
and L3MBTL2 [16]. Therefore, we analyzed the Dmc1, Paqr6 and
Rims3 promoters for the presence of these proteins. ChIP analysis
revealed that all four proteins are abundantly present on the
promoters in Sp3wtMEFs but strongly reduced in Sp3ki/ki and Sp3-/-
MEFs (Figure 5). The recruitment of these chromatin-modifying
Figure 5. Sp3-SUMO–dependent association of heterochromatic histone modifications and repressive chromatin components.
Sp3wt, Sp3ki/ki and Sp3-/- MEFs were subjected to ChIP analysis with the indicated antibodies. Precipitated DNA was amplified by qPCR with
promoter-specific primers for Dmc1, Rims3 and Paqr6. The locations of the primers are indicated as filled arrowheads in the schematic presentation of
the promoters in Figure 6. DNA recoveries are expressed as percentage of input (mean +/2SD).
doi:10.1371/journal.pgen.1001203.g005
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proteins to the endogenous Dmc1, Paqr6 and Rims3 promoters is thus
dependent on the presence of the Sp3 SUMO moiety. Taken
together, these results support the conclusion that the posttransla-
tional modification of Sp3 at K551 provokes a local repressive
chromatin structure on a subset of spermatocyte- and neuronal-
specific genes in somatic and non-neuronal cells, respectively.
Repression of many nervous system-specific genes in unrelated
tissues has been attributed to the corepressor CoREST1.
CoREST1 is recruited to promoters by the transcriptional
repressor REST/NRSF [30] and, alternatively, by a REST/
NRSF-independent mechanism that involves direct interaction
between CoREST1 and a thus far unknown SUMO2/3-modified
transcription factor [31]. To examine whether CoREST1 is also
involved in silencing the Dmc1, Paqr6 and Rims3 promoters, we
performed ChIP analysis for the presence of CoREST1.
CoREST1 was to some extent detectable on the Rims3 promoter
but not on the Dmc1 and Paqr6 promoters irrespectively of the Sp3
SUMOylation status (Figure S2). This finding indicates that
SUMOylation of Sp3 represents an alternative, CoREST1-
independent pathway mediating extra-neuronal repression.
SUMO modification of Sp3 is essential for DNA
methylation of target genes
An EMBOS CpGPlot analysis (http://www.ebi.ac.uk/Tools/
emboss/cpgplot/index.html) revealed that the Dmc1, Paqr6 and
Rims3 promoters are embedded in CpG islands. CpG island
methylation may contribute to silencing of these genes in MEFs and
may be reversed in Sp3ki/ki and Sp3-/- MEFs. Therefore, we
analyzed the methylation states of these promoters in Sp3wt, Sp3ki/ki
and Sp3-/- MEFs. Bisulfite sequencing revealed that the proximal
promoters and the first exons of the Dmc1, Paqr6 and Rims3 genes
are highly methylated in Sp3wtMEFs. In contrast, CpGmethylation
is strongly reduced in Sp3ki/ki and in Sp3-/- MEFs (Figure 6). In
summary, there is a very tight correlation between SUMO
Figure 6. SUMOylation-dependent CpG methylation of the Dmc1, Paqr6, and Rims3 genes. The methylation state of individual CpGs in
Sp3wt, Sp3ki/ki and Sp3-/- MEFs was analyzed by bisulfite sequencing of ten clones. Non-methylated CpGs are indicated as open squares and
methylated CpGs as filled squares. The promoters along with the position of Sp3 binding sites and the first exon are depicted schematically. Vertical
lines depict the positions of CpG dinucleotides. Unfilled arrowheads indicate the locations of the primers used for PCR, and filled arrowheads indicate
the locations of the primers used for the ChIP experiments shown in Figure 5.
doi:10.1371/journal.pgen.1001203.g006
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modification of Sp3, transcriptional repression, repressive histone
modifications and DNA methylation of these promoters. Lack of
SUMOylation of Sp3 results in their de-repression accompanied by
the absence of repressive histone modifications and the absence of
CpG methylation.
Discussion
The generation and analysis of mice with a subtle point
mutation in the SUMO attachment site of the transcription factor
Sp3 has revealed the relevance of SUMO modification of Sp3 for
gene silencing in vivo. SUMO attachment to Sp3 serves as a
molecular beacon for the recruitment of chromatin-modifying
machineries that impose epigenetic silencing on a subset of
spermatocyte-specific and neuronal genes. Our data are consistent
with the bidirectional crosstalk between repressive histone
modification and DNA methylation, that was established by
demonstrating direct interactions between SETDB1 and the de
novo methylase DNMT3A [32]. However, SETDB1 may also be
recruited indirectly through interaction with the methyl-CpG
binding protein MBD1 that forms a stable complex with SETDB1
[33]. We note that a functional SUMO interaction motif (SIM) is
present in the histone methyltransferase SETDB1 [34] and that
potential SIMs are also present in DNMTs. Thus, SUMO-
modified Sp3 might recruit SETDB1 and DNMTs independently.
Sp3-SUMO-mediated repression might involve a timely coordi-
nated recruitment of chromatin remodelers, nucleosome compac-
tors such as MBT domain proteins, HMTs and DNMTs.
Alternatively, these different types of epigenetic players might be
recruited simultaneously. The Sp3ki/ki and Sp3-/- MEFs described
here provide essential tools for future experiments addressing these
questions.
The lack of Sp3 SUMOylation in Sp3ki/ki mice causes aberrant
expression of several spermatocyte-specific and neuronal genes in
various somatic tissues. Although de-repression of these genes is
best described by the loss of the repressive function of
SUMOylated Sp3 in Sp3ki/ki mice, it is conceivable that the
activation function of the Sp3E553D mutant protein may
contribute directly or indirectly to the aberrant expression of
these genes as well. However, expression of the spermatocyte-
specific and neuronal genes in testis and brain, respectively, is not
affected. This tissue-selectivity could be due to low-level Sp3
SUMOylation in spermatocytes and neurons. To investigate this,
we performed Western blot analysis of testis and brain extracts.
Consistent with the lack of repression in testis and brain,
SUMOylated Sp3 species were barely detectable in these tissues
(Figure S3). Future studies using purified spermatocytes and
neurons might provide further insight on the cell type-specific
SUMOylation state of Sp3. Interestingly, it has been reported that
Sp3 expression in germ cells declines during the leptotene to
pachytene transition whereas the related transcription factor Sp1
did not decline until the mid-pachytene phase of meiosis [35].
Dmc1 is expressed in leptotene to zygotene spermatocytes [19],
and Dnahc8 from mid-pachytene to diplotene spermatocytes [18].
Thus, activation of the Dmc1 and Dnahc8 genes at these meiotic
stages correlates with down-regulation of Sp3. Accordingly, one
could image a scenario in which down-regulation of the Sp3
protein level facilitates Sp1-mediated activation of these two Sp3-
SUMO target genes during spermatocyte development.
The promoters of the three Sp3-SUMO target genes that we
analyzed in detail share several features. They contain multiple
GC-boxes, lack a TATA box and are embedded in CpG islands.
Such a promoter arrangement is reminiscent of housekeeping
genes. In contrast to the three Sp3 target genes, housekeeping
genes are ubiquitously expressed and remain unmethylated in all
tissues. It is currently unclear why the three Sp3 target genes are
expressed in such a highly tissue-specific manner. We have not
detected obvious features in the spacing or orientation of Sp-
binding sites that can account for this interesting difference.
Further investigations comparing these two types of promoters are
required to address this enigmatic point.
The aberrant expression of several testicular and neuronal genes
in Sp3ki/ki mice apparently does not lead to obvious histological or
behavioral abnormalities under standard mouse housing condi-
tions indicating that essential functions of differentiated cell types
are not grossly impaired. We note that the overall amounts of
aberrantly produced mRNA transcripts in somatic extra-neuronal
cells are low. This provides an explanation for the absence of clear
anatomical and physiological anomalies in the Sp3ki/ki mice.
The phenotype of the Sp3ki/ki mice differs significantly from
mice lacking the entire Sp3 protein. Sp3-deficient mice display
skeletal, tooth, hematopoietic and heart defects at late embryonic
development, and die immediately after birth due to respiratory
failure [24,36–38]. Given that SUMOylation-deficient Sp3
proteins are strong activators [13,14] the defects observed in
Sp3-/- mice have to be attributed largely to the activation function
of Sp3.
Materials and Methods
Ethics statement
Research involving mice have been conducted according to the
German Animal Protection Law (Tierschutzgesetz). The applica-
tion for the experiments was reviewed and approved by the
responsible local authorities (Regierungspra¨sidium Giessen, refer-
ence number V 54–19 c 20/15 cMR20/27).
Generation of Sp3ki/ki mice
A targeting vector containing the Sp3E553D mutation was
constructed and transfected into ES cells (Text S1). For selection of
ES cells, we used a floxed IRES-LacZ-neo-polyA cassette that
integrates into intron 5 of the Sp3 gene by homologous
recombination. A single clone out of.200 G418-resistant colonies
showed the homologous recombination event. After karyotyping,
the ES clone was injected into C57BL/6 blastocysts. Breeding of
the chimeras revealed germ-line transmission of the targeted Sp3
allele. The IRES-lacZ-neo cassette was removed by mating
heterozygous mice with mice expressing the Cre recombinase
under control of the cytomegalovirus-immediate early enhancer-
chicken beta-actin hybrid (CAG) promoter [17]. Offspring were
genotyped by Southern blotting and PCR (Figure S1). The Sp3wt/
ki heterozygous offspring were intercrossed and homozygous
Sp3ki/ki mice were obtained.
Retroviral infections
Retroviral vectors for expression of the long and short isoforms
of Sp3 and corresponding SUMOylation-deficient mutants were
generated by cloning of appropriate wild type and mutant Sp3
cDNA fragments [14] into the pBABE-puro plasmid. Retroviral
packaging in Phoenix cells and infection of immortalized Sp3-/-
MEFs [24] were performed according to standard procedures.
Transduced cells were selected for uptake of retrovirus with 2 mg/
mL of puromycin.
Western blotting
Whole cell extract from MEFs and mouse tissues were prepared
as described [7], separated on SDS-polyacrylamide gels, blotted on
PVDF membranes and probed with anti Sp3 antibodies (Santa
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Cruz Biotechnology, sc-644). Secondary antibodies were visualized
using the Immobilon Western HRP substrate (Millipore).
Expression profiling
Total RNAwas prepared from freshly isolated Sp3wt and Sp3ki/ki
mouse embryonic fibroblasts of E13.5 siblings using the RNeasy kit
(Qiagen). Purified RNA was labeled with the two-color Quick-Amp
Labeling kit (Agilent) and hybridized to a whole genome microarray
4x44K 60mer slide (G4122F) according to the manufacturer’s
instructions (Agilent). Microarray data were analyzed using
Bioconductor [39]. The loess method implemented in the
Bioconductor package marray was applied for normalization.
Two biological replicates (male and female MEFs) were performed.
Genes were considered as regulated when they had a fold change of
$2, a logarithmic intensity value (base 2) of $5 in Sp3ki/ki, and
when the expression level of replicates were similar. Similarity for
two log2 transformed expression levels was determined ad hoc by
the constraint max(1, |e1, e2|60.75,) . |e1 – e2|.
Data deposition
Microarray data were deposited at ArrayExpress (www.ebi.ac.
uk/arrayexpress) under accession number E-MEXP-2755.
Quantitative real-time PCR
One microgram of total RNA prepared from MEFs and mouse
organs was used for cDNA synthesis along with 0.5 mg of oligo(dT)
primer and 200 U of M-MLV reverse transcriptase (Invitrogen).
Quantitative RT-PCR was performed with 1 mL of 1:20 diluted
cDNA using gene-specific primers (Text S1). qPCRs were
performed in quadruplicate using the Absolute SYBRGreen
qPCR Mix (Abgene) on the Mx3000P real-time PCR system
(Stratagene). Values were normalized to Gapdh and/or Sp1
mRNA content.
Chromatin immunoprecipitation
Chromatin immunoprecipitation was performed using the One
Day ChIP kit (Diagenode) in accordance to the manufacturer’s
instructions. Primer sequences specific for Dmc1, Paqr6 and Rims3
promoter regions can be found in Text S1. Antibodies used for
ChIP analysis are described in [16].
Bisulfite sequencing
For DNA methylation analysis, 2 mg of genomic DNA derived
from immortalized Sp3wt, Sp3-/- and Sp3ki/ki MEFs were
subjected to sodium bisulfite conversion of unmethylated cytosines
using the EpiTect Bisulfite Kit (Qiagen) in accordance to the
manufacturer’s instructions. Converted DNA was subjected to
PCR amplification using promoter-specific BamHI- and KpnI-
tailed primers (Text S1) and the ImmoMix PCR reagent (Bioline).
PCR products were cloned into the pcDNA3 vector and 10 clones
were sequenced using the BGHrev primer.
Supporting Information
Figure S1 Targeting the mouse Sp3 SUMO site. (A) Top,
schematic representation of Sp3 protein structure. The glutamine-
rich activation domains A and B, the SUMO attachment site
(IKEE) within the inhibitory domain (ID) and the zinc fingers
(black bars) of the DNA binding domain as well as the translational
start sites and the length of the four different isoforms (781, 769,
496 and 479 aa) of Sp3 are indicated. Connecting lines with the
corresponding murine Sp3 gene regions show the derivation of the
inhibitory domain of the Sp3 protein from exon 5. In the targeting
vector, exon 5 was replaced by the mutagenized exon and a floxed
cassette containing a splice acceptor site (En2-SA), an internal
ribosomal entry site (IRES) and a lacZ-neomycin fusion gene (lacZ-
Neo) [ Mountford, et al]. The positions of the BglII (B) sites, the
probe used for Southern blotting (B-probe) and the lengths of the
corresponding DNA fragments are given as well. (B) Restriction of
genomic DNA with BglII and hybridization with the probe
indicated in (A) detected a 6.7 kb fragment of the wild type allele
and a 10.6 kb fragment of the mutated allele. (C) Schematic
presentation of the Sp3ki allele after removal of the selection
cassette by crossing targeted heterozygous mice with CAG-driven
Cre recombinase expressing mice. (D) Southern blot analysis after
EcoRV restriction revealed successful deletion of the selection
cassette. (E) PCR strategy for genotyping of Sp3ki mice. The Sp3wt
allele, the Sp3ki allele, the position of allele-specific primers
(arrows) and the lengths of the amplicons are depicted. The black
arrowhead in the Sp3ki allele represents the remaining loxP site
after removal of the lacZ-neo cassette. (F) PCR analysis. Sequence-
specific primers for the Sp3wt and the Sp3ki alleles and a common
intronic reverse primer produce 728 bp and 762 bp DNA
fragments, respectively. (G) Lack of Sp3 SUMOylation in tissues
and MEFs of Sp3ki/ki mutant mice. Mouse lung and spleen tissue
samples, and MEFs obtained from E13.5 embryos as well as from
Sp3wt (wt/wt) and Sp3ki/ki mice (ki/ki) were subjected to
immunoblot analyses with antibodies specific for Sp3. The asterisk
indicates an aspecific band. [Mountford P, Zevnik B, Duwel A,
Nichols J, Li M, et al. (1994) Dicistronic targeting constructs:
reporters and modifiers of mammalian gene expression. Proc Natl
Acad Sci USA 91: 4303-4307.]
Found at: doi:10.1371/journal.pgen.1001203.s001 (2.18 MB TIF)
Figure S2 Sp3-SUMO-dependent silencing of the Dmc1, Paqr6
and Rims3 promoters is independent of CoREST. Sp3wt (wt),
Sp3ki/ki and Sp3-/- MEFs were subjected to ChIP analysis with a
CoREST-specific antibody. The glutamate receptor M4 promoter
was used as positive control [30]. Precipitated DNA was amplified
by qPCR with primers for the M4, Dmc1, Paqr6 and Rims3
promoters. DNA recoveries are expressed as percentage of input
(mean +/2 SD).
Found at: doi:10.1371/journal.pgen.1001203.s002 (0.09 MB TIF)
Figure S3 Sp3 expression in mouse testis and brain. Mouse
testis, brain and lung protein samples from adult Sp3wt (wt) and
Sp3ki/ki mice (ki) were subjected to immunoblot analyses with anti
Sp3 antibodies. Two different exposure times of the blots are
shown. The asterisks indicate uncharacterized Sp3 isoforms or
aspecific bands. The SUMOylated small isoforms could not
assigned to specific signals.
Found at: doi:10.1371/journal.pgen.1001203.s003 (1.02 MB TIF)
Table S1 Genotype distribution of Sp3wt/ki intercrossings.
Found at: doi:10.1371/journal.pgen.1001203.s004 (0.03 MB
DOC)
Table S2 List of differentially expressed genes identified by
expression profiling.
Found at: doi:10.1371/journal.pgen.1001203.s005 (0.03 MB
XLS)
Text S1 Supporting materials and methods. Generation of the
Sp3 knockin homologous recombination construct. Genotyping of
targeted Sp3 knockin mice by PCR. Transfection of ES cells and
generation of chimeric and Sp3 SUMOylation-deficient mice.
Primers for RT-qPCR. Primers for promoter/exon amplification
and cloning after bisulfite treatment.
Found at: doi:10.1371/journal.pgen.1001203.s006 (0.04 MB
DOC)
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